Klona Biotech Inc.


Develops a bioprinting platform engineered to fabricate fibrous, mechanically robust human tissues by controlling fiber architecture, materials, and printing hardware/software. Initial programs target 3D-printed implants for tendon and ligament repair with preclinical evaluation and plans to extend the platform to other structural tissues.

Industries

Biotechnology
Health Care
Manufacturing
Medical
Biotechnology Research

Nr. of Employees

small (1-50)

Klona Biotech Inc.

New York, New York, United States


Products

Tendon repair implant (3D-printed fibrous implant)

A 3D-printed implant engineered to replicate the fibrous structure and mechanical strength of native tendons, intended to reinforce injured tissue during healing.

Meniscus repair (platform extension)

Planned extension of the printing platform to compressive, load-bearing tissues where fiber alignment and mechanics are critical.

On-demand personalized implant manufacturing (future)

Vision for producing patient-specific regenerative implants on demand using the bioprinting platform to enable hospital-based production.


Services

Development and manufacture of 3D-printed fibrous implants and the underlying hardware, software, and materials to produce them.

Expertise Areas

  • Fibrous tissue engineering
  • 3D bioprinting platform development
  • Biomaterials for extracellular matrix scaffolds
  • Preclinical implant evaluation
  • Show More (3)

Key Technologies

  • 3D bioprinting
  • Fiber-aligned scaffold fabrication
  • Collagen-based extracellular matrix materials
  • Slicing and printer-control software
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.